Bill117th CongressFiled Sep 14, 2022Health
H.R. 8828
FDA Ethics Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Sep 14, 2022)
FDA Ethics Act of 2022
This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.
What just happenedSep 15, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Kuster, Ann M. [D-NH-2](D-NH)Sponsor
1committees4actions
- Introduced in HouseSep 14, 2022
- Sep 15, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 14, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Sep 14, 2022IntroReferralIntro-H
Introduced in House
- Sep 14, 2022IntroReferral1000
Introduced in House